Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL 3 lurasidone dose trial in acute schizophrenia
ISRCTN64695913Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of lurasidone in schizophrenia (4 arms), sponsored by Sumitomo Pharma America. Started Oct 2008; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ISRCTN64695913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64695913.